Biomarkers for nasopharyngeal carcinoma
Authors:
- 19 March 2025
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 572, 120257
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA as noninvasive diagnostic markers for gastric cancerGastric Cancer, 2024
- Down-regulated lncRNA ROR in tumor-educated platelets as a liquid-biopsy biomarker for nasopharyngeal carcinomaJournal of Cancer Research and Clinical Oncology, 2022
- Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian CancerJAMA Oncology, 2022
- Clinical and survival analysis of nasopharyngeal carcinoma with consistently negative Epstein–Barr virus DNAHead & Neck, 2021
- Epstein‐Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic countryInternational Journal of Cancer, 2020
- Identification of a 7‐microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detectionCancer Medicine, 2019
- A novel and non‐invasive approach utilising nasal washings for the detection of nasopharyngeal carcinomaInternational Journal of Cancer, 2019
- The Role of DNA Methylation in Cancer2016
- Circulating Epstein–Barr virus microRNAs miR‐BART7 and miR‐BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatmentInternational Journal of Cancer, 2014
- Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, ChinaInternational Journal of Cancer, 2000